These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32626714)

  • 1. Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor.
    Barendsen RW; Dijkstra IME; Visser WF; Alders M; Bliek J; Boelen A; Bouva MJ; van der Crabben SN; Elsinghorst E; van Gorp AGM; Heijboer AC; Jansen M; Jaspers YRJ; van Lenthe H; Metgod I; Mooij CF; van der Sluijs EHC; van Trotsenburg ASP; Verschoof-Puite RK; Vaz FM; Waterham HR; Wijburg FA; Engelen M; Dekkers E; Kemp S
    Front Cell Dev Biol; 2020; 8():499. PubMed ID: 32626714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
    Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
    J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
    Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
    Front Neurol; 2022; 13():1072256. PubMed ID: 36698902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn Screening for X-Linked Adrenoleukodystrophy.
    Moser AB; Jones RO; Hubbard WC; Tortorelli S; Orsini JJ; Caggana M; Vogel BH; Raymond GV
    Int J Neonatal Screen; 2016 Dec; 2(4):. PubMed ID: 31467997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines.
    Vogel BH; Bradley SE; Adams DJ; D'Aco K; Erbe RW; Fong C; Iglesias A; Kronn D; Levy P; Morrissey M; Orsini J; Parton P; Pellegrino J; Saavedra-Matiz CA; Shur N; Wasserstein M; Raymond GV; Caggana M
    Mol Genet Metab; 2015 Apr; 114(4):599-603. PubMed ID: 25724074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
    Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
    Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
    Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
    JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for adrenoleukodystrophy: implications for therapy.
    Raymond GV; Jones RO; Moser AB
    Mol Diagn Ther; 2007; 11(6):381-4. PubMed ID: 18078355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
    Wiens K; Berry SA; Choi H; Gaviglio A; Gupta A; Hietala A; Kenney-Jung D; Lund T; Miller W; Pierpont EI; Raymond G; Winslow H; Zierhut HA; Orchard PJ
    Am J Med Genet A; 2019 Jul; 179(7):1205-1213. PubMed ID: 31074578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn Screen.
    Regelmann MO; Kamboj MK; Miller BS; Nakamoto JM; Sarafoglou K; Shah S; Stanley TL; Marino R;
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4324-4331. PubMed ID: 30289543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy.
    Ramirez Alcantara J; Grant NR; Sethuram S; Nagy A; Becker C; Sahai I; Stanley T; Halper A; Eichler FS
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1306-e1315. PubMed ID: 37220095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of Patients with Adrenoleukodystrophy towards Sex-Specific Newborn Screening.
    Yska HAF; Henneman L; Barendsen RW; Engelen M; Kemp S
    Int J Neonatal Screen; 2023 Sep; 9(3):. PubMed ID: 37754777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Changing Face of Adrenoleukodystrophy.
    Zhu J; Eichler F; Biffi A; Duncan CN; Williams DA; Majzoub JA
    Endocr Rev; 2020 Aug; 41(4):577-93. PubMed ID: 32364223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
    van de Beek MC; Dijkstra IM; van Lenthe H; Ofman R; Goldhaber-Pasillas D; Schauer N; Schackmann M; Engelen-Lee JY; Vaz FM; Kulik W; Wanders RJ; Engelen M; Kemp S
    PLoS One; 2016; 11(4):e0154597. PubMed ID: 27124591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoleukodystrophy in the era of newborn screening.
    Eng L; Regelmann MO
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):47-55. PubMed ID: 31789721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impacts of adrenoleukodystrophy newborn screening on the evaluation of adrenal dysfunction in male children: An integrative literature review.
    Pitts L; White JM; Ladores S; Wilson CM
    J Pediatr Nurs; 2023; 72():e53-e70. PubMed ID: 37331834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up.
    Matteson J; Sciortino S; Feuchtbaum L; Bishop T; Olney RS; Tang H
    Int J Neonatal Screen; 2021 Apr; 7(2):. PubMed ID: 33920672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration.
    Huffnagel IC; Laheji FK; Aziz-Bose R; Tritos NA; Marino R; Linthorst GE; Kemp S; Engelen M; Eichler F
    J Clin Endocrinol Metab; 2019 Jan; 104(1):118-126. PubMed ID: 30252065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania.
    Priestley JRC; Adang LA; Drewes Williams S; Lichter-Konecki U; Menello C; Engelhardt NM; DiPerna JC; DiBoscio B; Ahrens-Nicklas RC; Edmondson AC; Reynoso Santos FJ; Ficicioglu C
    Int J Neonatal Screen; 2022 Mar; 8(2):. PubMed ID: 35466195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.